Stock Price Quote

ALBERT DAVID LTD.

NSE : ALBERTDAVDBSE : 524075ISIN CODE : INE155C01010Industry : Pharmaceuticals & DrugsHouse : Private
BSE718.20-7.85 (-1.08 %)
PREV CLOSE ( ) 726.05
OPEN PRICE ( ) 729.95
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 236
TODAY'S LOW / HIGH ( )705.70 732.95
52 WK LOW / HIGH ( )581.3 959.35
NSE717.10-6.15 (-0.85 %)
PREV CLOSE( ) 723.25
OPEN PRICE ( ) 724.70
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 717.10 (3)
VOLUME 7443
TODAY'S LOW / HIGH( ) 708.50 730.80
52 WK LOW / HIGH ( )579.9 957.5
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 1938
Management Info
Arun Kumar Kothari - Chairman - Managing Director
Registered Office

Address D Block, 3rd Floor,Gillander House 8,Netaji Subhas Road,
Kolkata,
West Bengal-700001

Phone 033 22628436 / 8456 / 8492 / 8439

Email albertdavid@adlindia.in

Website www.albertdavidindia.com

Registrars Details
Maheshwari Datamatics Pvt Ltd
23 RN Mukherjee Road, ,5th Floor (Old Address: 6 Mangaoe Lane 2nd Floor),,kokata
Listing : BSE, NSE

NEWS

17Jan Albert David informs about change in m
Albert David has informed that Snehal Tushar Bhosale, Executive Assistan..
22Dec Albert David informs about trading win
Albert David has informed that Trading Window for dealing in the shares..
27Feb Albert David informs about disclosure
Albert David has informed that the exchange has received the disclosure..
19Sep Albert David informs about closure of
In terms the SEBI (Prohibition of Insider Trading) Regulations, 2015, as..
23Aug Albert David informs about details of
Albert David has informed under Regulation 39(3) of the SEBI (Listing Ob..

Financials

in Millions
QTR Dec 25 ANNUAL 25
Net Profit153.03172.01
Gross Profit 199.02 252.28
Operating Profit 232.24326.07
Net Sales 899.273457.68

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Neuland Laboratories (BSE)
peergroup  15301.65 (2.11%)
M.Cap ( in Cr)19631.85
RPG Life Sciences (BSE)
peergroup  2025.85 (6.63%)
M.Cap ( in Cr)3350.56
Pfizer (BSE)
peergroup  4954.05 (1.74%)
M.Cap ( in Cr)22663.66
Kwality Pharma (BSE)
peergroup  1747.00 (4.01%)
M.Cap ( in Cr)1812.72
Gland Pharma (BSE)
peergroup  1795.80 (3.44%)
M.Cap ( in Cr)29586.96

Shareholding Pattern

PROMOTERS 62.24%
NON-INSTITUTION 35.5%
FI/BANKS/INSURANCE 1.62%
MUTUAL FUNDS/UTI 0.01%
GOVERNMENT 0%
FII 0%

About Albert David Ltd.

Albert David Ltd. was incorporated in the year 1938. Its today's share price is 718.2. Its current market capitalisation stands at Rs 409.89 Cr. In the latest quarter, company has reported Gross Sales of Rs. 3713.18 Cr and Total Income of Rs.3753.49 Cr. The company's management includes Rajiv Anant Desai, Anand Vardhan Kothari, Prabhawati Devi Kothari, Naresh Pachisia, Monjori Mitra, Shourya Sengupta, Anurag Singhi, Arun Kumar Kothari, Lalit Lohia.

It is listed on the BSE with a BSE Code of 524075 , NSE with an NSE Symbol of ALBERTDAVD and ISIN of INE155C01010. It's Registered office is at D Block, 3rd Floor,Gillander House 8,Netaji Subhas RoadKolkata-700001, West Bengal. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are Basu Chanchani & Deb, G Basu & Co, LB Jha & Co

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.